Diafir
Develops, manufactures and markets in situ and fast biological analytical tools based upon unique infra red fiber sensor technology.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor | €0.0 | round | |
€800k | Seed | ||
| Total Funding | 000k | ||
Related Content
Diafir, founded in 2011 by researchers from Rennes 1 University, France, is a medical technology company specializing in innovative diagnostic solutions. The company has developed a proprietary platform that utilizes mid-infrared spectroscopy to analyze the metabolic signature spectrum of blood serum within minutes. This technology is particularly effective for screening and diagnosing Non-Alcoholic Steatohepatitis (NASH) and other diseases. Diafir serves healthcare providers, including hospitals and diagnostic labs, operating in the medical diagnostics market. The business model is centered around the sale and distribution of its diagnostic devices and related services. Revenue is generated through the direct sale of these devices, as well as through partnerships and collaborations with healthcare institutions and research organizations.
Keywords: mid-infrared spectroscopy, serum diagnostics, NASH, disease detection, healthcare providers, diagnostic labs, medical technology, proprietary platform, rapid screening, metabolic signature.